Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
about
Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions.Clinical importance and epidemiology of quinolone resistance.Characterization of Staphylococcus aureus from distinct geographic locations in China: an increasing prevalence of spa-t030 and SCCmec type III.Antibiotics, acne, and Staphylococcus aureus colonizationTransmission of methicillin-resistant Staphylococcus aureus via deceased donor liver transplantation confirmed by whole genome sequencing.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.ASSOCIATION OF HIV WITH BREAST ABSCESS AND ALTERED MICROBIAL SUSCEPTIBILITY PATTERNS.Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout MutantsAntimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review.Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.Molecular epidemiology of hospital-onset methicillin-resistant Staphylococcus aureus infections in Southern Chile.Clinical outcomes by methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type: isolates recovered from a phase IV clinical trial of linezolid and vancomycin for complicated skin and skin structure infectionsCharacterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.Linezolid-resistant cfr-positive MRSA, Italy.
P2860
Q33605347-3F562E58-9F53-450B-9A7E-465FB7BA6792Q34838791-E1801A54-570C-4F69-8039-E1D15B5D21D7Q35157240-088C8CBC-6707-4446-9A2D-A834FCB95FBEQ35571602-5F19FA5D-0ECF-41DA-9F05-4E8661995011Q36295908-5E048D68-366D-49D9-A1B0-D7DC65B7EE90Q36337074-AD669F5C-EBCC-44E4-B757-0748596E5016Q36363012-31878765-4C26-4E4C-9BDF-1AB4E5179028Q36406438-EF52789E-ECF8-4C1C-9E95-0E41D822440EQ36434414-A49472D9-EBE5-4807-903E-F6453828296BQ37819539-AB6F9B68-3231-44FB-88D0-4D98B23FE3A5Q37998398-C8B680AE-A8F4-4712-A9F6-E543486297C7Q38164663-3D65BD08-2724-4D6A-9621-0B1B2DEA4BA9Q38502317-919ABC6B-2AB2-409A-89E3-2F6C1BCD7BB3Q40166186-322CFD3F-3A81-4A59-965D-AE2E6AEAD669Q41919138-A02AA1F2-E799-4347-8580-7D9EE5007C93Q42259050-7B5DDED9-AC5B-4BF7-B2D3-EDABB5CB9383Q42430265-14D68B90-6E8F-4105-BFAD-B4DD2B51A607Q44814819-431A12AD-181F-404F-8C1A-1BE066455488Q50870773-0ACFD880-2B2C-4787-8997-5B69A9494EC8
P2860
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Characterization of baseline m ...... clinical trial for linezolid.
@en
Characterization of baseline m ...... clinical trial for linezolid.
@nl
type
label
Characterization of baseline m ...... clinical trial for linezolid.
@en
Characterization of baseline m ...... clinical trial for linezolid.
@nl
prefLabel
Characterization of baseline m ...... clinical trial for linezolid.
@en
Characterization of baseline m ...... clinical trial for linezolid.
@nl
P2093
P2860
P356
P1476
Characterization of baseline m ...... clinical trial for linezolid.
@en
P2093
Binh An Diep
Henry F Chambers
Lalitagauri M Deshpande
Rodrigo E Mendes
Ronald N Jones
P2860
P304
P356
10.1128/JCM.01384-09
P407
P577
2009-11-25T00:00:00Z